Oramed Announces Oravax’s Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial October 29, 2021 Press Releases
Oramed to Present at Cantor Fitzgerald Virtual Global Healthcare Conference September 23, 2021 Press Releases
Oramed’s Phase 2 Oral Insulin NASH Trial Reaches Over 50% Enrollment September 15, 2021 Press Releases
Oramed to Present at H.C. Wainwright 23rd Annual Global Investment Conference September 9, 2021 Press Releases
Oramed Reaches 25% Enrollment in Its Second of Two Concurrent Phase 3 Oral Insulin Trials August 24, 2021 Press Releases
Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and Metabolism August 16, 2021 Press Releases
